The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade. (Q52726598)
Jump to navigation
Jump to search
scientific article published in March 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade. |
scientific article published in March 2018 |
Statements
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade. (English)
David A Schaer
Richard P Beckmann
Jack A Dempsey
Lysiane Huber
Amelie Forest
Nelusha Amaladas
Yanxia Li
Ying Cindy Wang
Erik R Rasmussen
Darin Chin
Andrew Capen
Carmine Carpenito
Kirk A Staschke
Linda A Chung
Lacey M Litchfield
Farhana F Merzoug
Xueqian Gong
Philip W Iversen
Sean Buchanan
Alfonso de Dios
Ruslan D Novosiadly
Michael Kalos
1 March 2018
22
11
2978-2994